[Technical challenges and preventive countermeasures of robotic gastric cancer surgery].
1/5 보강
Over the past two decades, the surgical treatment of gastric cancer has witnessed remarkable transformations.
APA
Zhou YB (2025). [Technical challenges and preventive countermeasures of robotic gastric cancer surgery].. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery, 28(8), 865-869. https://doi.org/10.3760/cma.j.cn441530-20250715-00269
MLA
Zhou YB. "[Technical challenges and preventive countermeasures of robotic gastric cancer surgery].." Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery, vol. 28, no. 8, 2025, pp. 865-869.
PMID
40850830 ↗
Abstract 한글 요약
Over the past two decades, the surgical treatment of gastric cancer has witnessed remarkable transformations. It has evolved from traditional open - surgery to laparoscopic minimally - invasive surgery, and subsequently to robot - assisted surgery. The robotic surgical system, owing to its distinctive advantages, has been gradually applied and popularized in gastric cancer surgeries. Nevertheless, it inevitably gives rise to specific technical blind spots and operational challenges.This paper systematically reviews the classification of intraoperative errors in robotic gastric cancer surgery and their clinical implications. It proposes a grading standard for bleeding, explores the identification and prevention strategies of hazard zones, and underscores the core values of meticulous preoperative planning, the standardized operation, and teamwork. Simultaneously, in light of the impact of tissue edema and fibrosis following neoadjuvant therapy on surgery, corresponding grading standards are established. The objective is to offer a valuable reference for clinical practice and facilitate the standardized and precise development of robotic gastric cancer surgery.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (1)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.